Antimicrobial Peptide Therapeutics for Cystic Fibrosis
نویسندگان
چکیده
منابع مشابه
Antimicrobial peptide therapeutics for cystic fibrosis.
Greater than 90% of lung infections in cystic fibrosis (CF) patients are caused by Pseudomonas aeruginosa, and the majority of these patients subsequently die from lung damage. Current therapies are either targeted at reducing obstruction, reducing inflammation, or reducing infection. To identify potential therapeutic agents for the CF lung, 150 antimicrobial peptides consisting of three distin...
متن کاملCystic fibrosis microbiology: Advances in antimicrobial therapy.
Much of the improvement in the survival of individuals with cystic fibrosis (CF) is due to advancements in antimicrobial treatments. New aerosolized antibiotic formulations have recently been introduced (such as inhaled aztreonam), and others are in development (inhaled levofloxacin and liposomal amikacin). Licensed dry powder formulations include tobramycin inhalation powder and dry powder col...
متن کاملProgress in cystic fibrosis and the CF Therapeutics Development Network.
Cystic fibrosis (CF), the most common life-shortening genetic disorder in Caucasians, affects approximately 70 000 individuals worldwide. In 1998, the Cystic Fibrosis Foundation (CFF) launched the CF Therapeutics Development Network (CF-TDN) as a central element of its Therapeutics Development Programme. Designed to accelerate the clinical evaluation of new therapies needed to fulfil the CFF mi...
متن کاملAntimicrobial peptides in the real world: implications for cystic fibrosis.
T he continuous cycle of respiratory infections and lung inflammation is a hallmark of cystic fibrosis (CF) lung disease and plays a central role in respiratory failure that develops in end-stage disease. Effective mucociliary clearance is an essential mechanism in host defence against infection and requires a functional ‘‘two-layer’’ mucus clearance system composed of a periciliary liquid laye...
متن کاملAntiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
Cystic Fibrosis (CF) is the most common fatal inherited disease of Caucasians, affecting about 1 in 3000 births. Patients with CF have a recessive mutation in the gene encoding the CF transmembrane conductance regulator (CFTR). CFTR is expressed in the epithelium of many organs throughout the exocrine system, however, inflammation and damage of the airways as a result of persistent progressive ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Antimicrobial Agents and Chemotherapy
سال: 2005
ISSN: 0066-4804,1098-6596
DOI: 10.1128/aac.49.7.2921-2927.2005